We pinpointed the top candidate genes (BARD1, HSD17B12, ZMYM1, SH3BGR, GSKIP, CBL, WDR81), showing P-value lower than 0.001, whose expression changes were predicted to affect NB risk. This evidence concerns the gene CBL and neuroblastoma.